On this pinboard, we will publish projects that have been granted the use of SCQM data. Accepted studies will be published here for 2 months to allow interested researchers to express their wish to collaborate in the project.
We encourage Swiss rheumatologists to collaborate in the research projects on SCQM data. Should you be interested to hear more about a certain project and potentially want to collaborate in a project, please contact the SCQM scientific manager: email@example.com.
Impact of national treatment guidelines, schedules of reimbursement and gross domestic product on treatment outcomes in patients treated with b/tsDMARDs across European observational spondyloarthritis registries. Study lead: Adrian Ciurea (USZ), SCQM project number: 2021_07, date accepted by Foundation Board: 22.07.2022
Gender-attributable differences in patient reported outcome measures in axial spondyloarthritis. Study lead: Raphael Micheroli (USZ), SCQM project number: 2022_01, date accepted by Foundation Board: 22.07.2022
Treatment retention in SpA patients assessed with methods for interval- censored time-to-event data. Study lead: Adrian Ciurea (USZ), SCQM project number: 2021_11, date accepted by Foundation Board: 22.07.2022
International collaboration projects are listed for information only. In most cases, inclusion of additional collaborators is not possible due to restriction in the number of project participants per country.